Mayzent

Active Ingredient(s): Siponimod
FDA Approved: * March 26, 2019
Pharm Company: * NOVARTIS PHARMS CORP
Category: Multiple Sclerosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Mayzent Overview

Siponimod, marketed under the trade name Mayzent, is a selective sphingosine-1-phosphate receptor modulator for oral use that is used for multiple sclerosis (MS). It is intended for once-daily oral administration.[2][dead link] Contents 1 Medical uses 2 Adverse effects 3 Pharmacology 3.1 Mechanism of action 4 Society and culture 4.1 Legal status 5 References Medical uses Siponimod was studied for the treatment of secondary progressive multiple sc...

Read more Mayzent Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Siponimod

Recent Mayzent Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Siponimod
  • Tablet: 0.25mg, 2mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Mayzent: (2 results)

Sorted by National Drug Code
  • 0078-0979 Mayzent .25 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation
  • 0078-0986 Mayzent 2 mg Oral Tablet, Film Coated by Novartis Pharmaceuticals Corporation

Other drugs which contain Siponimod or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 20 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA